(Ottawa) Health Canada has approved the use of the estrogen vaccine, bringing the number of COVID-19 vaccines available to Canadians to three to date.
Canada has signed an agreement to provide 20 million doses of the vaccine. The first delivery of at least one million doses is expected by the end of March. A government source confirmed Press Conclusion of Health Canada. The vaccine was developed by the University of Oxford in association with the pharmaceutical company AstraZeneca and has been in use in the UK for several weeks.
Vaccines produced by Pfizer-Bioentech and Moderna were approved in December.
Prime Minister Justin Trudeau, Health Minister Patti Hajdu and Public Services and Supplies Minister Anita Anand are due to provide further details on the vaccine during a press conference on Friday afternoon.
Minister Anand has already pointed out that by the end of June, Canada will be able to receive nearly two million doses of AstraZeneca vaccine, thanks to the Kovacs mechanism, an initiative to provide global and equal access to the vaccine to less fortunate countries. These amounts are to be included in the amount of 20 million that Canada is to receive under the contract signed with the company.
So with the advent of this third vaccine the national vaccination campaign will be accelerated in the coming weeks.
On Thursday, the Trudeau government confirmed that supplies would increase between April and June.
Major General Danny Ford, who is in charge of vaccine distribution logistics at the Public Health Institute of Canada, said at a press conference that Pfizer-Bioentech will deliver 769,000 doses of the vaccine per week for the first two weeks of April. He could not provide details about the Moderna during the same period, but again, the speed would increase.
Since December, Canada has received 2.5 million doses of both vaccines, of which 1.5 million have been administered. Overall, 2.9% of Canadians received at least one dose and 1.1% received two injections.
In Quebec, 387,076 levels have been managed to date. So 4.4% of the population received the first dose. No one gets a second; The second dose injection should begin in mid-March.
Health Canada evaluates two more vaccines, manufactured by Johnson & Johnson and NovaVox.